TY  - JOUR
AU  - Rodriguez-Diaz, Cristina
AU  - Taminiau, Bernard
AU  - García-García, Alberto
AU  - Cueto, Alejandro
AU  - Robles-Díaz, Mercedes
AU  - Ortega-Alonso, Aida
AU  - Martín-Reyes, Flores
AU  - Daube, Georges
AU  - Sanabria-Cabrera, Judith
AU  - Jimenez-Perez, Miguel
AU  - Isabel Lucena, M
AU  - Andrade, Raúl J
AU  - García-Fuentes, Eduardo
AU  - García-Cortes, Miren
PY  - 2022
DO  - 10.1016/j.phrs.2022.106348
UR  - http://hdl.handle.net/10668/22473
T2  - Pharmacological research
AB  - The gut microbiota could play a significant role in the progression of nonalcoholic fatty liver disease (NAFLD); however, its relevance in drug-induced liver injury (DILI) remains unexplored. Since the two hepatic disorders may share damage pathways,...
LA  - en
KW  - Drug induced liver injury, non-alcoholic fatty liver disease
KW  - Gut microbiota
KW  - Liver fibrosis
KW  - Metabolic pathways
KW  - Metagenomic
KW  - Bacteria
KW  - Chemical and Drug Induced Liver Injury
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Liver
KW  - Liver Cirrhosis
KW  - Metagenome
KW  - Non-alcoholic Fatty Liver Disease
TI  - Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury.
TY  - research article
VL  - 182
ER  -